Immediate Impact
28 standout
Citing Papers
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2025 Standout
Chronic kidney disease
2025 Standout
Works of Patrick H. Nachman being referenced
Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Patrick H. Nachman | 9 | 158 | 15 | 55 | 50 | 2 | 160 | |
| David Pitcher | 11 | 148 | 24 | 45 | 50 | 6 | 152 | |
| Yunfei Bao | 11 | 95 | 18 | 40 | 32 | 4 | 140 | |
| Julie Bex-Coudrat | 33 | 171 | 9 | 40 | 66 | 4 | 219 | |
| Urjana Poreci | 36 | 154 | 6 | 46 | 49 | 2 | 211 | |
| E. Loiacono | 14 | 82 | 7 | 15 | 24 | 2 | 105 | |
| Zhiling Guo | 18 | 117 | 12 | 30 | 42 | 6 | 172 | |
| Nikki Graham | 70 | 116 | 24 | 39 | 66 | 5 | 209 | |
| Tarun Kumar Saha | 27 | 227 | 21 | 15 | 83 | 3 | 242 | |
| Tala Dajani | 43 | 142 | 15 | 7 | 35 | 4 | 182 | |
| Amy Fearn | 58 | 124 | 9 | 10 | 19 | 6 | 223 |
All Works
Loading papers...